11 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
at Shire Plc (acquired by Takeda Pharmaceutical), including Senior Vice President of Finance, Division Chief Financial Officer for the Regenerative
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
by Takeda Pharmaceutical), including Senior Vice President of Finance, Division Chief Financial Officer for the Regenerative Medicine Division and Head
POS AM
0dbxsdmg
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
424B3
vtu3b
30 Nov 23
Prospectus supplement
5:18pm
8-K
5uej27mrpzl9nui
28 Nov 23
Appoints CEO and Additional Directors, and Expands Leadership Team to
7:33am
- Prev
- 1
- Next